Smyth, Elizabeth C.
Lagergren, Jesper
Fitzgerald, Rebecca C.
Lordick, Florian
Shah, Manish A.
Lagergren, Pernilla
Cunningham, David
Article History
First Online: 27 July 2017
Competing interests
: E.C.S. declares honoraria for an advisory role from Five Prime Therapeutics and Bristol-Myers Squibb. D.C. declares institutional research funding from Amgen, AstraZeneca, Bayer, Celgene, MedImmune, Merck Serono, Merrimack and Sanofi. F.L. has received research support from GlaxoSmithKline and Fresenius Biotech; lecture and advisory honoraria from Amgen, Biontech, Bristol-Myers Squibb, Eli Lilly, Ganymed, Merck Serono, MSD, Nordic and Roche; and travel support from Amgen, Bayer, Roche and Taiho. M.A.S. declares institutional research funding from Genentech, Sanofi and Lilly. J.L., P.L. and R.C.F. are named on patents related to the Cytosponge and associated assays, which have been licensed by the Medical Research Council to Covidien (now Medtronic).